| Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3 … YJ Bang, E Van Cutsem, A Feyereislova, HC Chung, L Shen, A Sawaki, ... The Lancet 376 (9742), 687-697, 2010 | 7847 | 2010 |
| Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial K Shitara, M Özgüroğlu, YJ Bang, M Di Bartolomeo, M Mandalà, MH Ryu, ... The Lancet 392 (10142), 123-133, 2018 | 1137 | 2018 |
| Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial K Shitara, T Doi, M Dvorkin, W Mansoor, HT Arkenau, A Prokharau, ... The Lancet Oncology 19 (11), 1437-1448, 2018 | 427 | 2018 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 212 | 2023 |
| Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial J Ocvirk, T Brodowicz, F Wrba, TE Ciuleanu, G Kurteva, S Beslija, I Koza, ... World journal of gastroenterology: WJG 16 (25), 3133, 2010 | 138 | 2010 |
| Clinical outcomes of patients with advanced gastrointestinal stromal tumors: Safety and efficacy in a worldwide treatment‐use trial of sunitinib P Reichardt, YK Kang, P Rutkowski, J Schuette, LS Rosen, B Seddon, ... Cancer 121 (9), 1405-1413, 2015 | 133 | 2015 |
| Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations GN Tsaousis, E Papadopoulou, A Apessos, K Agiannitopoulos, G Pepe, ... BMC cancer 19, 1-19, 2019 | 126 | 2019 |
| Metronomic chemotherapy: a systematic review of the literature and clinical experience C Simsek, E Esin, S Yalcin Journal of oncology 2019, 2019 | 126 | 2019 |
| Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: A … B Schultheis, D Reuter, MP Ebert, J Siveke, A Kerkhoff, WE Berdel, ... Annals of Oncology 28 (10), 2429-2435, 2017 | 126 | 2017 |
| Yeast culture supplementation to laying hen diets containing soybean meal or sunflower seed meal and its effect on performance, egg quality traits, and blood chemistry S Yalçin, B Özsoy, H Erol Journal of Applied Poultry Research 17 (2), 229-236, 2008 | 97 | 2008 |
| Bevacizumab+ Capecitabine as Maintenance Therapy after Initial Bevacizumab+ XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop … S Yalcin, R Uslu, F Dane, U Yilmaz, N Zengin, E Buyukunal, ... Oncology 85 (6), 328-335, 2013 | 86 | 2013 |
| Neuropathic cancer pain: What we are dealing with? How to manage it? E Esin, S Yalcin OncoTargets and therapy, 599-618, 2014 | 85 | 2014 |
| Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival FP Turkoz, M Solak, S Kilickap, A Ulas, O Esbah, B Oksuzoglu, S Yalcin Journal of Gastric Cancer 14 (3), 164, 2014 | 83 | 2014 |
| Gastric cancer in Turkey—a bridge between West and East S Yalcin Gastrointestinal cancer research: GCR 3 (1), 29, 2009 | 76 | 2009 |
| A review of the use of somatostatin analogs in oncology O Keskin, S Yalcin OncoTargets and therapy, 471-483, 2013 | 71 | 2013 |
| Evaluation of dietary and life-style habits of patients with gastric cancer: a case-control study in Turkey E Yassibaş, P Arslan, Ş YALÇIN Asian Pacific Journal of Cancer Prevention 13 (5), 2012 | 63 | 2012 |
| Induction chemotherapy with cisplatin and 5‐fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of … O Altundag, I Gullu, K Altundag, S Yalcin, E Ozyar, M Cengiz, F Akyol, ... Head & neck 27 (1), 15-21, 2005 | 63 | 2005 |
| Diagnosis and management of cholangiocarcinomas: a comprehensive review. S Yalcin Hepato-gastroenterology 51 (55), 43-50, 2004 | 62 | 2004 |
| Evaluation of quality of life and anxiety and depression levels in patients receiving chemotherapy for colorectal cancer: impact of patient education before treatment initiation U Polat, A Arpacı, S Demir, S Erdal, Ş Yalcin Journal of gastrointestinal oncology 5 (4), 270, 2014 | 59 | 2014 |
| Current and future systemic treatment options in metastatic pancreatic cancer C Arslan, S Yalcin Journal of gastrointestinal oncology 5 (4), 280, 2014 | 58 | 2014 |
